Drug:
Reaction: GAIT DISTURBANCE
20260101 - 20261231
No. 1001 - 1100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1001 | 26761091 |
US |
60 | 1 |
Gait disturbance, |
||||
| 1002 | 26761175 |
EU |
63 | 2 |
Anxiety, Flatulence, Gait disturbance, Neuropathy peripheral, Tachycardia, Dyspepsia, Balance disorder, Diarrhoea, Hypertension, Dizziness, Tinnitus, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, IRBESARTAN, BISOPROLOL FUMARATE, ELIGLUSTAT, |
||||
| 1003 | 26761339 |
US |
88 | 2 |
Nausea, Mobility decreased, Gait disturbance, |
||||
MAVACAMTEN, IBUPROFEN SODIUM, IBUPROFEN, IBUPROFEN TABLETS, COATED, |
||||
| 1004 | 26761371 |
US |
2 | |
Gait disturbance, Pain, Intestinal perforation, Memory impairment, Amnesia, |
||||
TOCILIZUMAB, TOCILIZUMAB, |
||||
| 1005 | 26761438 |
47 | 2 | |
Depression, Cerebrovascular accident, Gait disturbance, Hypoaesthesia, Muscular weakness, Facial paralysis, |
||||
OFATUMUMAB, |
||||
| 1006 | 26761896 |
EU |
79 | 2 |
Contusion, Pain, Feeling abnormal, Malaise, Gait disturbance, |
||||
POLIDOCANOL, |
||||
| 1007 | 26761988 |
CA |
44 | 2 |
Adverse drug reaction, Adverse event, Amnesia, Anxiety, Blood cholesterol increased, Breast cancer stage III, Chest pain, Decreased appetite, Delirium, Depression, Diarrhoea, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Exposure during pregnancy, Fibromyalgia, Gait disturbance, Grip strength decreased, Headache, Hypertension, Hypoaesthesia, Joint range of motion decreased, Live birth, Liver injury, Malaise, Memory impairment, Mobility decreased, Muscular weakness, Musculoskeletal stiffness, Nausea, Oedema, Prescribed overdose, Therapy non-responder, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE, OXYCODONE, OXYCODONE, PREDNISOLONE ACETATE, OXYCODONE HYDROCHLORIDE, OXYCODONE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ERENUMAB-AOOE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, LEFLUNOMIDE, LEFLUNOMIDE, APREMILAST, CALCIUM CARBONATE, ANTACID, CALCIUM CARBONATE, ANTACID, CANDESARTAN, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, VEDOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SARILUMAB, SARILUMAB, PREGABALIN, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NEOMYCIN OINTMENT, NEOMYCIN OINTMENT, APREMILAST, APREMILAST, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREGABALIN, PREGABALIN, METHYLPREDNISOLONE SODIUM SUCCINATE, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB, TOFACITINIB CITRATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, |
||||
| 1008 | 26768461 |
71 | 2 | |
Chills, Myalgia, Pyrexia, Rhinorrhoea, Fatigue, Gait disturbance, Hypersomnia, Malaise, |
||||
EVOLOCUMAB, |
||||
| 1009 | 26752252 |
CA |
64 | 2 |
Rheumatoid arthritis, Pain in extremity, Inappropriate schedule of product administration, Asthenia, Oropharyngeal pain, Limb discomfort, Arthralgia, Injection site erythema, Fatigue, Musculoskeletal stiffness, Gait disturbance, Malaise, COVID-19, Hepatotoxicity, Illness, Pain, Swelling, Off label use, Autoimmune disorder, Tooth infection, Injection site pruritus, Contusion, |
||||
METHOTREXATE, METHOTREXATE SODIUM, SARILUMAB, SARILUMAB, SARILUMAB, SARILUMAB, INDAPAMIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, CYCLOSPORINE, ROSUVASTATIN, ESOMEPRAZOLE SODIUM, LEVOTHYROXINE SODIUM, |
||||
| 1010 | 26752263 |
US |
73 | 1 |
Surgery, Herpes zoster, Pain, Back pain, Pain in extremity, Gait disturbance, Rheumatoid arthritis, Back disorder, |
||||
UPADACITINIB, UPADACITINIB, |
||||
| 1011 | 26752559 |
US |
2 | |
Off label use, Gait disturbance, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LORAZEPAM, FISH OIL, GABAPENTIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, VITAMIN E, |
||||
| 1012 | 26752563 |
US |
92 | 2 |
Hospitalisation, Asthenia, Memory impairment, Hypoacusis, Gait disturbance, Gastrointestinal obstruction, Intestinal stenosis, Illness, |
||||
ADALIMUMAB, ADALIMUMAB, |
||||
| 1013 | 26752912 |
US |
2 | |
Gait disturbance, Product dose omission issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1014 | 26752913 |
US |
1 | |
Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1015 | 26753157 |
GB |
66 | 2 |
Abdominal distension, Muscular weakness, Gait disturbance, Palpitations, Paraesthesia oral, Fatigue, Insomnia, Abdominal pain upper, Pruritus, Pain, Diarrhoea, |
||||
ZOLEDRONIC ACID, |
||||
| 1016 | 26753268 |
US |
60 | 1 |
Renal impairment, Gait disturbance, Dizziness, Burning sensation, Peripheral swelling, Condition aggravated, |
||||
AGALSIDASE BETA, |
||||
| 1017 | 26753386 |
GB |
46 | |
Pain, Mental impairment, Gait disturbance, Lip swelling, Vision blurred, Disturbance in attention, Speech disorder, Paraesthesia, Dyspnoea, Eye swelling, Pyrexia, Diplopia, Intentional dose omission, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 1018 | 26753734 |
US |
79 | 2 |
Gait disturbance, |
||||
| 1019 | 26753865 |
BR |
1 | |
Quadriparesis, Facial paralysis, Miller Fisher syndrome, Polyneuropathy, Guillain-Barre syndrome, Gait disturbance, Ataxia, Inappropriate schedule of product administration, |
||||
| 1020 | 26754384 |
EU |
75 | |
Diffuse large B-cell lymphoma, Joint stiffness, Gait disturbance, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 1021 | 26754413 |
CA |
43 | 2 |
Liver disorder, Lower limb fracture, Lung disorder, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Pyrexia, Rash, Rheumatoid arthritis, Rheumatoid factor positive, Sinusitis, Sleep disorder, Sciatica, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Weight decreased, Wheezing, Wound infection, Confusional state, Deep vein thrombosis postoperative, Decreased appetite, Depression, Diarrhoea, Discomfort, Delirium, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Facet joint syndrome, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Gait disturbance, Grip strength decreased, Drug intolerance, Off label use, Treatment failure, Product use in unapproved indication, Contraindicated product administered, |
||||
APREMILAST, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CALCIUM, CALCIUM, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREGABALIN, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, VITAMIN C, ERGOCALCIFEROL, ERGOCALCIFEROL, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 1022 | 26754588 |
GB |
76 | 2 |
Cataract, Dry mouth, Fatigue, Gait disturbance, Mood swings, Visual impairment, Diarrhoea, Faeces discoloured, Limb discomfort, |
||||
USTEKINUMAB, |
||||
| 1023 | 26754770 |
US |
69 | 2 |
Pneumonia, Renal impairment, Blood glucose abnormal, Urinary retention, Pain in extremity, Gait disturbance, Muscular weakness, Incorrect product administration duration, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1024 | 26754776 |
US |
70 | 1 |
Parkinson^s disease, Gait disturbance, Tremor, Product use in unapproved indication, Posture abnormal, |
||||
DEUTETRABENAZINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LISDEXAMFETAMINE DIMESYLATE, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, AMLODIPINE, DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE, AZELASTINE, CLONAZEPAM, DOLUTEGRAVIR SODIUM AND LAMIVUDINE, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, ZOLPIDEM TARTRATE, |
||||
| 1025 | 26755438 |
US |
65 | 2 |
Oxygen saturation decreased, Heart rate increased, Abdominal distension, Constipation, Gait disturbance, Diarrhoea, |
||||
TADALAFIL, TREPROSTINIL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, CETIRIZINE HYDROCHLORIDE, FUROSEMIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ESCITALOPRAM OXALATE, ESCITALOPRAM, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, LINACLOTIDE, ALBUTEROL SULFATE, CEFDINIR, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, BACLOFEN, BUSPIRONE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, OXYGEN, 0XYGEN, DAPAGLIFLOZIN, DULOXETINE HYDROCHLORIDE, DULOXETINE, PRAMIPEXOLE DIHYDROCHLORIDE, ORAL SEMAGLUTIDE, |
||||
| 1026 | 26756884 |
US |
80 | 1 |
Hypotension, COVID-19, Dizziness, Gait disturbance, Dyspnoea, Urinary tract infection, Lethargy, Nausea, Pruritus, Dizziness, Paraesthesia, Contusion, Skin induration, Blister, Oedema peripheral, Peripheral swelling, Pigmentation disorder, Varicose vein, Urinary tract infection, |
||||
IBRUTINIB, IBRUTINIB, LOSARTAN, |
||||
| 1027 | 26757085 |
US |
78 | 2 |
Malaise, Oropharyngeal pain, Nausea, Dizziness, Muscular weakness, Headache, Hypoaesthesia, Sleep disorder due to a general medical condition, Gait disturbance, Axillary pain, Paraesthesia, Condition aggravated, Glossodynia, Back pain, Abdominal pain upper, Ocular hyperaemia, Dyspnoea, Eyelid skin dryness, Chest discomfort, Pain in extremity, Oxygen saturation decreased, Muscular weakness, Bone swelling, Lacrimation increased, Arthralgia, Eye pain, Eye inflammation, Dry eye, Foreign body sensation in eyes, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BIOTIN, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, LORATADINE, LORATADINE ORAL, MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, VITAMIN C, ERGOCALCIFEROL, |
||||
| 1028 | 26757090 |
JP |
22 | 2 |
Suicide attempt, Hyperhidrosis, Gait disturbance, Decreased activity, Dizziness, Nausea, Irritability, Lacrimation increased, |
||||
ZURANOLONE, |
||||
| 1029 | 26757286 |
US |
85 | 2 |
Stoma creation, Rash, Gait disturbance, Back pain, Neck pain, Arthralgia, Kidney infection, White blood cell count increased, Blood magnesium decreased, Diarrhoea, Drug ineffective, Cartilage atrophy, Drug intolerance, |
||||
UPADACITINIB, UPADACITINIB, UPADACITINIB, UPADACITINIB, BARICITINIB, |
||||
| 1030 | 26747309 |
US |
62 | 2 |
Pain in extremity, Arthralgia, Joint swelling, Gait disturbance, Joint effusion, Pyrexia, Myalgia, |
||||
TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, PREDNISONE, |
||||
| 1031 | 26747436 |
US |
13 | 2 |
Gait disturbance, Balance disorder, Gait inability, Adverse drug reaction, Developmental regression, Flatulence, Gastrointestinal disorder, Diarrhoea, Mobility decreased, Grip strength decreased, Irritability, Abdominal distension, Condition aggravated, Musculoskeletal stiffness, Abnormal behaviour, Underdose, |
||||
TROFINETIDE, TROFINETIDE, TROFINETIDE, |
||||
| 1032 | 26747999 |
RU |
19 | 1 |
Pneumothorax, Dyspnoea, Neurofibromatosis, Nervous system disorder, Gait disturbance, Pain, |
||||
SELUMETINIB, |
||||
| 1033 | 26748077 |
US |
57 | 1 |
Mental status changes, Toxicity to various agents, Schizophrenia, Fall, Chest discomfort, Acute psychosis, Gait disturbance, Asthenia, Product use issue, |
||||
AMANTADINE, PERPHENAZINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, DIVALPROEX SODIUM, LORAZEPAM, SEVELAMER CARBONATE, |
||||
| 1034 | 26748167 |
CA |
82 | 2 |
Urinary tract infection, Hospitalisation, Furuncle, Erythema, Vaginal prolapse, Condition aggravated, Gait disturbance, Intestinal prolapse, Cystocele, Genital haemorrhage, Injection site pruritus, Injection site swelling, Injection site pain, Injection site erythema, Off label use, Gastrointestinal disorder, Illness, Injection site urticaria, Malaise, Post procedural haemorrhage, Urethral prolapse, Cognitive disorder, Pain, Asthma, Vaginal haemorrhage, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
| 1035 | 26748225 |
EU |
68 | 1 |
Death, Condition aggravated, Confusional state, Hallucination, Gait disturbance, Obsessive thoughts, Urinary tract infection, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1036 | 26748530 |
US |
82 | 2 |
Neuropathy peripheral, Injection site haemorrhage, Injection site indentation, Exposure via skin contact, Injury associated with device, Device difficult to use, Spondylitis, Gait disturbance, Wrong technique in device usage process, |
||||
EVOLOCUMAB, GLIPIZIDE, INSULIN GLARGINE, INSULIN ASPART, |
||||
| 1037 | 26748553 |
57 | ||
Neurotoxicity, Gait disturbance, Fall, Asthenia, Chest discomfort, Hypertension, Tachypnoea, Nervous system disorder, Acute psychosis, Hallucination, Patient uncooperative, Somnolence, Behaviour disorder, Mental status changes, Toxicity to various agents, Cognitive disorder, Agitation, Extrapyramidal disorder, |
||||
AMANTADINE HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, PERPHENAZINE, DIVALPROEX SODIUM, LORAZEPAM, SEVELAMER CARBONATE, |
||||
| 1038 | 26748555 |
28 | ||
Hyperammonaemia, Oxygen saturation decreased, Encephalopathy, Aggression, Dysarthria, Confusional state, Gait disturbance, Agitation, Drug interaction, Multiple drug therapy, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, LITHIUM, LITHIUM BROMATUM, DIVALPROEX SODIUM, CLOZAPINE, VALPROIC ACID, PROPRANOLOL HYDROCHLORIDE, |
||||
| 1039 | 26749015 |
CA |
59 | 1 |
Intestinal obstruction, Bradycardia, Hereditary angioedema, Hereditary angioedema, Hereditary angioedema, Hereditary angioedema, Hereditary angioedema, Hereditary angioedema, Hereditary angioedema, Drug ineffective, Hereditary angioedema, Intestinal obstruction, Hereditary angioedema, Cerebrovascular accident, Anosmia, Hemiplegia, Hereditary angioedema, Hereditary angioedema, Chest discomfort, COVID-19, Off label use, Back pain, Gait disturbance, Hepatic steatosis, Off label use, Abdominal symptom, Mental fatigue, Fatigue, Stress, Influenza, Infection, Depressed mood, |
||||
AMLODIPINE BESYLATE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, MONTELUKAST SODIUM, TRAMADOL HYDROCHLORIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MOMETASONE FUROATE, ALBUTEROL SULFATE, DEXTROAMPHETAMINE SULFATE, DANAZOL, CARVEDILOL, NITROGLYCERIN, SPIRONOLACTONE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, RIVAROXABAN, PREGABALIN, UMECLIDINIUM, HYDROMORPHONE HYDROCHLORIDE, BACLOFEN, MAGNESIUM, ISOSORBIDE DINITRATE, CYANOCOBALAMIN, ISOSORBIDE DINITRATE, DEXTROAMPHETAMINE SULFATE, SPIRONOLACTONE, METHYLPREDNISOLONE ACETATE, |
||||
| 1040 | 26749113 |
US |
2 | |
Constipation, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, |
||||
| 1041 | 26749654 |
CA |
2 | |
Abdominal pain, Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthralgia, Arthropathy, Blister, Asthenia, Blood cholesterol increased, Bursitis, C-reactive protein abnormal, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspnoea, Ear pain, Fatigue, Fibromyalgia, Gait disturbance, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Joint range of motion decreased, Pemphigus, Pericarditis, Rash, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Wheezing, Wound, Wound infection, Vomiting, Live birth, Maternal exposure during pregnancy, Condition aggravated, Breast cancer stage III, Intentional product use issue, |
||||
TOPIRAMATE, TOPIRAMATE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, INFLIXIMAB, LAMOTRIGINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OXYCODONE HYDROCHLORIDE, OXYCODONE, QUETIAPINE FUMARATE, QUETIAPINE, RAMIPRIL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, |
||||
| 1042 | 26749707 |
US |
72 | 2 |
Acute kidney injury, Dehydration, Confusional state, Fall, Breast cancer, Adrenal insufficiency, Constipation, Dysphonia, Weight decreased, Arthralgia, Paraesthesia, Hypoaesthesia, Blood pressure decreased, Diarrhoea, Aphonia, Scab, Blood pressure abnormal, Feeling cold, Epistaxis, Asthenia, Fatigue, Alopecia, Gait disturbance, Peripheral swelling, Rash macular, Hypertension, Headache, Blood sodium decreased, Ear discomfort, Faeces discoloured, Blood phosphorus increased, Malignant neoplasm progression, Cancer pain, Drug ineffective, Dizziness, Loss of consciousness, Pain in extremity, Pain, Blood potassium increased, Sciatica, Lymphoedema, |
||||
LENVATINIB, LENVATINIB, LENVATINIB, TORSEMIDE, PEMBROLIZUMAB, |
||||
| 1043 | 26750275 |
CO |
70 | 2 |
Cerebral thrombosis, Gait disturbance, |
||||
DUPILUMAB, |
||||
| 1044 | 26750596 |
2 | ||
Gait disturbance, Product dose omission issue, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 1045 | 26750722 |
US |
2 | |
Hepatic failure, Rhinorrhoea, Off label use, Ammonia increased, Wrong technique in product usage process, Eyelid disorder, Hospitalisation, Drug hypersensitivity, Adverse event, Gait disturbance, Incorrect dose administered, Eye disorder, Device use issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, CALCIUM, ERGOCALCIFEROL, FUROSEMIDE, LACTULOSE, ALPRAZOLAM, SPIRONOLACTONE, |
||||
| 1046 | 26750912 |
US |
1 | |
Hallucination, visual, Gait disturbance, Speech disorder, |
||||
BUPRENORPHINE, ALPRAZOLAM, QUETIAPINE, GABAPENTIN, INSULIN DEGLUDEC, LISINOPRIL, EMPAGLIFLOZIN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, ORAL SEMAGLUTIDE, DEXTROAMPHETAMINE, |
||||
| 1047 | 26751174 |
US |
66 | 1 |
Infection, Gait disturbance, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 1048 | 26751795 |
CA |
26 | 1 |
Chills, Malaise, Gait disturbance, Balance disorder, Nausea, Confusional state, Memory impairment, Vital functions abnormal, Headache, Pyrexia, Fatigue, |
||||
RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, RAVULIZUMAB, |
||||
| 1049 | 26754494 |
41 | 1 | |
Gait disturbance, Dyschezia, Faeces discoloured, Abnormal faeces, Abdominal distension, Muscle spasms, Gastrointestinal disorder, Diarrhoea, Liver disorder, Blood bilirubin increased, Impaired work ability, Hunger, Tendon pain, Neuralgia, Pain in extremity, Tendon pain, Peripheral swelling, Nail disorder, Oedema, Fluid retention, Dysstasia, Feeling abnormal, Fear, Muscle disorder, Mental disorder, Loss of personal independence in daily activities, Burning sensation, Musculoskeletal stiffness, Product complaint, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, AMOXICILLIN AND CLAVULANATE POTASSIUM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, MAGNESIUM, |
||||
| 1050 | 26754764 |
68 | 2 | |
Dyskinesia, Adverse drug reaction, Flushing, Feeling hot, Neck pain, Gait disturbance, Anaesthetic complication, Documented hypersensitivity to administered product, |
||||
PROPOFOL, NORETHINDRONE ACETATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SPIRONOLACTONE, FAMOTIDINE, CIMETIDINE, OMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FAMOTIDINE 20MG, RANITIDINE HYDROCHLORIDE, |
||||
| 1051 | 26754923 |
32 | 2 | |
Somnolence, Gait disturbance, |
||||
ZURANOLONE, |
||||
| 1052 | 26741803 |
US |
68 | 2 |
Drug hypersensitivity, Influenza like illness, Peripheral swelling, Gait disturbance, Pain in jaw, Pain in extremity, |
||||
DUPILUMAB, |
||||
| 1053 | 26741825 |
US |
66 | 2 |
Arthritis, Gait disturbance, Arthralgia, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1054 | 26742011 |
EU |
65 | 1 |
Crohn^s disease, Arthropathy, Drug ineffective, Gait disturbance, Arthralgia, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, UPADACITINIB, |
||||
| 1055 | 26742028 |
US |
70 | 2 |
Gait disturbance, |
||||
MAVACAMTEN, |
||||
| 1056 | 26742214 |
CO |
76 | 2 |
Hypoaesthesia, Oedema peripheral, Thrombosis, Arthritis, Dyspnoea, Gait disturbance, Pain in extremity, Finger deformity, Arthralgia, Weight decreased, Pain, |
||||
ROMOSOZUMAB-AQQG, ROMOSOZUMAB-AQQG, ROMOSOZUMAB-AQQG, |
||||
| 1057 | 26742242 |
VE |
1 | |
Dystonia, Basal ganglion degeneration, Depressed level of consciousness, Quadriparesis, Unresponsive to stimuli, Gait disturbance, Bradykinesia, Dysarthria, Ataxia, Mitochondrial enzyme deficiency, Pallor, Psychomotor hyperactivity, Hypotonia, Stupor, Mutism, Scoliosis, Dysphagia, Irritability, Nasal congestion, |
||||
SEVOFLURANE, |
||||
| 1058 | 26742404 |
CO |
88 | 2 |
Pulmonary thrombosis, Mobility decreased, Ligament sprain, Gait disturbance, Pneumonia, Urinary tract infection, |
||||
DENOSUMAB, |
||||
| 1059 | 26742926 |
CA |
67 | 2 |
Ankylosing spondylitis, Large intestinal stenosis, Pain, Intervertebral disc protrusion, Gingival operation, Gait disturbance, Off label use, |
||||
INFLIXIMAB, INFLIXIMAB, PREDNISONE, |
||||
| 1060 | 26743856 |
US |
||
Drooling, Salivary hypersecretion, Productive cough, Decreased appetite, Coordination abnormal, Restless legs syndrome, Pain, Mental impairment, Gait disturbance, Fall, Somnolence, Product quality issue, |
||||
| 1061 | 26743962 |
US |
58 | 2 |
Chills, Dizziness, Gait disturbance, |
||||
TIRZEPATIDE, |
||||
| 1062 | 26744150 |
US |
53 | 2 |
Arthralgia, Pain, Gait disturbance, |
||||
DUPILUMAB, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 1063 | 26744345 |
|||
Peripheral swelling, Gait disturbance, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 1064 | 26744421 |
|||
Adverse drug reaction, Disorientation, Gait disturbance, |
||||
CLONAZEPAM, |
||||
| 1065 | 26745020 |
US |
2 | |
Hypersensitivity, Pain in extremity, Gait disturbance, |
||||
CIPROFLOXACIN HYDROCHLORIDE, |
||||
| 1066 | 26745527 |
28 | 1 | |
Oxygen saturation decreased, Leukocytosis, Hyperammonaemia, Aspiration, Toxicity to various agents, Diarrhoea, Drooling, Dysarthria, Confusional state, Gait disturbance, Agitation, Off label use, Coordination abnormal, Aggression, Headache, |
||||
ARIPIPRAZOLE LAUROXIL, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, LITHIUM, LITHIUM BROMATUM, LITHIUM, LITHIUM BROMATUM, DIVALPROEX SODIUM, DIVALPROEX SODIUM, PROPRANOLOL HYDROCHLORIDE, |
||||
| 1067 | 26745660 |
US |
1 | |
Cytokine release syndrome, Neurotoxicity, Tremor, Brain fog, Staring, Hypoacusis, Pain, Confusional state, Gait disturbance, Dysstasia, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 1068 | 26745814 |
US |
63 | 2 |
Pain, Gait disturbance, Burning sensation, |
||||
TIRZEPATIDE, |
||||
| 1069 | 26746111 |
US |
2 | |
Gait disturbance, Inflammatory marker increased, Arthralgia, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, BISOPROLOL FUMARATE, ETANERCEPT, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, FISH OIL, LOSARTAN POTASSIUM, LOSARTAN, NEMOLIZUMAB-ILTO, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), ERGOCALCIFEROL, |
||||
| 1070 | 26746390 |
US |
87 | 2 |
Arthralgia, Device use error, Gait disturbance, Device issue, Loss of personal independence in daily activities, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 1071 | 26746527 |
TR |
57 | 2 |
Auditory disorder, Malaise, Skin laxity, Facial paralysis, Gait disturbance, Headache, Rash macular, Rash, |
||||
ONABOTULINUMTOXINA, |
||||
| 1072 | 26746778 |
US |
75 | 1 |
Bipolar disorder, Generalised anxiety disorder, Gait disturbance, Fatigue, Insomnia, |
||||
VALBENAZINE, DIVALPROEX SODIUM, MIRTAZAPINE, ZOLPIDEM TARTRATE, ALPRAZOLAM, |
||||
| 1073 | 26746866 |
US |
78 | 1 |
Seizure, Diarrhoea, Gait disturbance, |
||||
RISANKIZUMAB-RZAA, |
||||
| 1074 | 26746926 |
US |
2 | |
Wrist fracture, Fall, Depression, Upper limb fracture, Gait disturbance, Hypoaesthesia, Malaise, Pain in extremity, Head injury, Dyspnoea, |
||||
DIROXIMEL FUMARATE, |
||||
| 1075 | 26746973 |
GB |
66 | 2 |
Pruritus, Diarrhoea, Abdominal distension, Pain, Palpitations, Insomnia, Muscular weakness, Paraesthesia oral, Gait disturbance, Fatigue, Abdominal pain upper, |
||||
ZOLEDRONIC ACID, |
||||
| 1076 | 26736336 |
US |
2 | |
Pain, Gait disturbance, Loss of personal independence in daily activities, |
||||
TOCILIZUMAB, TOCILIZUMAB, |
||||
| 1077 | 26736351 |
US |
65 | 1 |
Gait disturbance, Fatigue, |
||||
TOCILIZUMAB, PREDNISONE, ABATACEPT, DULOXETINE HYDROCHLORIDE, DULOXETINE, NIFEDIPINE, TICAGRELOR, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, QUINAPRIL, QUINAPRIL HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CAFFEINE, |
||||
| 1078 | 26736445 |
CN |
23 | 1 |
Overdose, Dizziness, Hallucination, Gait disturbance, Somnolence, |
||||
OLANZAPINE, DIVALPROEX SODIUM, |
||||
| 1079 | 26736480 |
38 | ||
Generalised tonic-clonic seizure, Rhabdomyolysis, Cerebellar atrophy, Acute kidney injury, Dysmetria, Liver injury, Loss of consciousness, Cerebellar syndrome, Altered state of consciousness, Seizure, Unresponsive to stimuli, Bronchospasm, Mental status changes, Dysphagia, Hyperthermia, Pyrexia, Dehydration, Bacterial infection, Muscle rigidity, Creatine kinase increased, Dysarthria, Dizziness, Diplopia, Vertigo, Sitting disability, Gait disturbance, Muscular weakness, Gait disturbance, Toxicity to various agents, Accidental overdose, |
||||
QUETIAPINE, LITHIUM, LITHIUM BROMATUM, |
||||
| 1080 | 26737051 |
US |
5 | 1 |
Injection site pain, Gait disturbance, |
||||
ARIPIPRAZOLE, ARIPIPRAZOLE, |
||||
| 1081 | 26737345 |
US |
85 | 1 |
Gait disturbance, Dysarthria, Fall, Skin abrasion, Head injury, |
||||
RELUGOLIX, RELUGOLIX, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, VITAMIN C, ERGOCALCIFEROL, DAROLUTAMIDE, |
||||
| 1082 | 26737487 |
EU |
8 | 1 |
Gait disturbance, Bradykinesia, Neurological decompensation, Mitochondrial enzyme deficiency, Basal ganglion degeneration, Vomiting, Hiccups, |
||||
SEVOFLURANE, |
||||
| 1083 | 26738284 |
AU |
32 | |
Status epilepticus, Dengue fever, Immune-mediated encephalitis, Blood HIV RNA increased, Progressive multifocal leukoencephalopathy, Vaginal dysplasia, Brain injury, Uterine polyp, Neurodermatitis, Dysarthria, Gait disturbance, Areflexia, Papilloma viral infection, Chills, Anaemia, Abnormal behaviour, Cervical dysplasia, |
||||
FLUCONAZOLE, MEDROXYPROGESTERONE ACETATE, |
||||
| 1084 | 26738440 |
US |
8 | 1 |
Heart rate irregular, Myositis, Fatigue, Fall, Dysstasia, Gait disturbance, Mobility decreased, Asthenia, Disease progression, General physical health deterioration, Muscle atrophy, Muscular weakness, Weight increased, |
||||
DELANDISTROGENE MOXEPARVOVEC-ROKL, VAMOROLONE, MELATONIN, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, CETIRIZINE HYDROCHLORIDE, ALBUTEROL SULFATE, ALBUTEROL, LISINOPRIL, |
||||
| 1085 | 26738554 |
CO |
71 | 2 |
Gait disturbance, Cartilage injury, |
||||
EVOLOCUMAB, |
||||
| 1086 | 26738644 |
EU |
68 | 1 |
Chest pain, Dyspnoea, Dizziness, Electrocardiogram QT prolonged, Extrasystoles, Pain, Gait disturbance, Off label use, |
||||
QUETIAPINE, QUETIAPINE, QUETIAPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, AMLODIPINE, |
||||
| 1087 | 26738686 |
TZ |
61 | 1 |
Pleurothotonus, Gait disturbance, |
||||
DONEPEZIL HYDROCHLORIDE, RISPERIDONE, |
||||
| 1088 | 26738830 |
96 | 2 | |
Product prescribing issue, Joint instability, Gait disturbance, Arthralgia, Muscular weakness, Groin pain, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 1089 | 26739437 |
US |
37 | 2 |
Nephrolithiasis, Lobular breast carcinoma in situ, Myelopathy, Breast mass, Nerve injury, Trigeminal neuralgia, Insomnia, Fatigue, Alopecia, Tooth loss, Muscle strength abnormal, Illness, Gait disturbance, Asthenia, Tremor, Blood pressure abnormal, Anxiety, |
||||
ASFOTASE ALFA, |
||||
| 1090 | 26739503 |
US |
41 | 1 |
Hypoaesthesia, Gait disturbance, Arthralgia, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1091 | 26739649 |
US |
64 | 2 |
Pneumonia, Medical device implantation, Thrombosis, Paralysis, Pain in extremity, Pulmonary thrombosis, Gait disturbance, Neuropathy peripheral, Cardiac disorder, Walking aid user, Malaise, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 1092 | 26739777 |
82 | 1 | |
Asthenia, Gait disturbance, Cardiac failure, Fluid retention, |
||||
FINERENONE, |
||||
| 1093 | 26739794 |
US |
65 | 2 |
Chronic obstructive pulmonary disease, Syncope, Tachycardia, Emphysema, Productive cough, Chest discomfort, Gait disturbance, Catathrenia, Sinus headache, Oropharyngeal pain, Pulmonary mass, Hepatic cyst, Sputum retention, |
||||
BENRALIZUMAB, BENRALIZUMAB, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, PREDNISONE, LOSARTAN POTASSIUM, LOSARTAN, PREGABALIN, EZETIMIBE, ALBUTEROL SULFATE, ACETAMINOPHEN AND CODEINE, |
||||
| 1094 | 26739846 |
US |
1 | |
Gait disturbance, |
||||
DAROLUTAMIDE, |
||||
| 1095 | 26740460 |
US |
64 | 2 |
Pruritus, Headache, Rash, Blister, Peripheral swelling, Joint swelling, Gait disturbance, Impaired work ability, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 1096 | 26740713 |
US |
59 | 2 |
Hepatitis, Hepatic steatosis, Pancreatitis, Odynophagia, Dry mouth, Oral pain, Oral discomfort, Insomnia, Gait disturbance, Nausea, Vomiting, Cough, Dyspepsia, Breath odour, Constipation, Urinary tract infection, Hypertension, Proteinuria, Back pain, Headache, Abdominal pain upper, Diarrhoea, |
||||
LENVATINIB, LENVATINIB, LENVATINIB, PEMBROLIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 1097 | 26740869 |
US |
43 | 2 |
Loss of personal independence in daily activities, Gait disturbance, Fatigue, Dyspnoea, Off label use, |
||||
TADALAFIL, TADALAFIL, TADALAFIL, TADALAFIL, |
||||
| 1098 | 26743768 |
49 | 1 | |
Dizziness, Gait disturbance, Malnutrition, |
||||
BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, |
||||
| 1099 | 26744268 |
70 | 2 | |
Musculoskeletal stiffness, Gait disturbance, Fear of falling, |
||||
ROPINIROLE, GABAPENTIN, |
||||
| 1100 | 26744541 |
56 | 2 | |
Confusional state, Gait disturbance, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
